Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-08

FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Fosrenol (lanthanum carbonate) from Takeda Pharmaceuticals America, Inc. The update pertains to the product's la…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FOSRENOL (lanthanum carbonate)

Snippet

SUPPL AP for FOSRENOL (LANTHANUM CARBONATE)